Chemotherapeutic Effect of Stigmasterol in Sorafenib Treated Breast Cancer Cell Lines via Modulation of NF-κB and ERK Signaling Pathways
Last updated: 01 Jan 2025
10.21608/ejchem.2023.204388.7825
breast cancer, Sorafenib, Stigmasterol, Angiogenesis, apoptosis
asmaa
elshamy
Faculty of pharmacy damanhour university
asmaa.elshamy@pharm.dmu.edu.eg
Gamal
Omran
Biochemistry Department, Faculty of Pharmacy, Damanhour University, Egypt, postal code: 22511
gamal.omran@pharm.dmu.edu.eg
Mohammad
Abd-Alhaseeb
Pharmacology and Toxicology Department, Faculty of Pharmacy, Damanhour University, Egypt, postal code: 22511
m.abdelhasseb@pharm.dmu.edu.eg
MAHA
HOUSSEN
Biochemistry department faculty of pharmacy Damanhour University
mahahoussen@pharm.dmu.edu.eg
67
3
45192
2024-03-01
2023-04-16
2024-03-01
227
234
0449-2285
2357-0245
https://ejchem.journals.ekb.eg/article_304622.html
https://ejchem.journals.ekb.eg/service?article_code=304622
304,622
Original Article
297
Journal
Egyptian Journal of Chemistry
https://ejchem.journals.ekb.eg/
Chemotherapeutic Effect of Stigmasterol in Sorafenib Treated Breast Cancer Cell Lines via Modulation of NF-κB and ERK Signaling Pathways
Details
Type
Article
Created At
30 Dec 2024